Literature DB >> 15723724

HPA binding and metastasis formation of human breast cancer cell lines transplanted into severe combined immunodeficient (scid) mice.

Ursula Valentiner1, Debbie M S Hall, Susan A Brooks, Udo Schumacher.   

Abstract

Six human breast cancer cell lines were injected subcutaneously into scid mice and their in vivo growth behaviour and HPA binding pattern were analysed. Furthermore, the role of HPA binding glycoconjugates concerning the adhesion to endothelial cells in vitro was investigated. Four of the tested cell lines engrafted in the scid mouse model but they showed considerable variations concerning their growth behaviour, their metastatic potential and their HPA binding pattern. HPA inhibited adhesive interactions between cell lines derived from metatstatic sources and tumour necrosis factor (TNF)alpha stimulated endothelial cells. The transplantation of HPA defined breast cancer cell lines into scid mice is a useful animal model for the research of breast cancer and its metastasis. The HPA binding glycoconjugates appear to be associated with adhesive interactions between metastasising tumour cells and endothelial cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15723724     DOI: 10.1016/j.canlet.2004.07.046

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  8 in total

1.  Expression of sphingosine-1-phosphate receptors and lysophosphatidic acid receptors on cultured and xenografted human colon, breast, melanoma, and lung tumor cells.

Authors:  Reinhard Müller; Christoph Berliner; Jessica Leptin; Daniel Pörtner; Wojciech Bialecki; Burkhard Kleuser; Udo Schumacher; Novica M Milićević
Journal:  Tumour Biol       Date:  2010-05-18

2.  YKL-40 protein expression in human tumor samples and human tumor cell line xenografts: implications for its use in tumor models.

Authors:  Lukas Clemens Böckelmann; Theresa Felix; Simona Calabrò; Udo Schumacher
Journal:  Cell Oncol (Dordr)       Date:  2021-08-25       Impact factor: 7.051

3.  Microarrays with varying carbohydrate density reveal distinct subpopulations of serum antibodies.

Authors:  Oyindasola Oyelaran; Qian Li; David Farnsworth; Jeffrey C Gildersleeve
Journal:  J Proteome Res       Date:  2009-07       Impact factor: 4.466

4.  Clinically proven markers of metastasis predict metastatic spread of human melanoma cells engrafted in scid mice.

Authors:  A Thies; S Mauer; O Fodstad; U Schumacher
Journal:  Br J Cancer       Date:  2007-01-30       Impact factor: 7.640

5.  Infiltration of Immune Competent Cells into Primary Tumors and Their Surrounding Connective Tissues in Xenograft and Syngeneic Mouse Models.

Authors:  Marlon Metzen; Michael Bruns; Wolfgang Deppert; Udo Schumacher
Journal:  Int J Mol Sci       Date:  2021-04-19       Impact factor: 5.923

6.  A newly generated functional antibody identifies Tn antigen as a novel determinant in the cancer cell-lymphatic endothelium interaction.

Authors:  Carla Danussi; Anna Coslovi; Cristiana Campa; Maria T Mucignat; Paola Spessotto; Fulvio Uggeri; Sergio Paoletti; Alfonso Colombatti
Journal:  Glycobiology       Date:  2009-06-15       Impact factor: 4.313

7.  E-/P-selectins and colon carcinoma metastasis: first in vivo evidence for their crucial role in a clinically relevant model of spontaneous metastasis formation in the lung.

Authors:  S Köhler; S Ullrich; U Richter; U Schumacher
Journal:  Br J Cancer       Date:  2009-12-15       Impact factor: 7.640

8.  Effect of the Expression of ELOVL5 and IGFBP6 Genes on the Metastatic Potential of Breast Cancer Cells.

Authors:  Sergey Nikulin; Galina Zakharova; Andrey Poloznikov; Maria Raigorodskaya; Daniel Wicklein; Udo Schumacher; Stepan Nersisyan; Jonas Bergquist; Georgy Bakalkin; Lidiia Astakhova; Alexander Tonevitsky
Journal:  Front Genet       Date:  2021-06-02       Impact factor: 4.599

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.